Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Clinical Epigenetics
|
December 14, 2021
High performance methylated DNA markers for detection of colon adenocarcinoma
Romy A M Klein Kranenbarg, Abdul Hussain Vali, Jan N M IJzermans, et al.
Cancer Biology & Therapy
|
September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors
Nilofer Azad, Alyssa Perroy, Erin Gardner, et al.
Cancer
|
April 24, 2019
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors
Stéphanie L Gaillard, Marianna Zahurak, Anup Sharma, et al.
Plos One
|
April 27, 2017
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
Anup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Cancer Metastasis Reviews
|
December 31, 2013
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
Sarah Derks, Arjen H G Cleven, Veerle Melotte, et al.
Plos One
|
November 30, 2020
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
Anup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Cancer Chemotherapy and Pharmacology
|
January 23, 2014
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
Edward Sausville, Patricia Lorusso, Michael Carducci, et al.
Cancer
|
January 3, 2013
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials
Jung-min Lee, John L Hays, Anne M Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 16, 2014
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors
Luis A Diaz, Christina M Coughlin, Susan C Weil, et al.
Investigational New Drugs
|
April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumors
James M Cleary, David A Reardon, Nilofer Azad, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Clinical Epigenetics
|
December 14, 2021
High performance methylated DNA markers for detection of colon adenocarcinoma
Romy A M Klein Kranenbarg, Abdul Hussain Vali, Jan N M IJzermans, et al.
Cancer Biology & Therapy
|
September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors
Nilofer Azad, Alyssa Perroy, Erin Gardner, et al.
Cancer
|
April 24, 2019
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors
Stéphanie L Gaillard, Marianna Zahurak, Anup Sharma, et al.
Plos One
|
April 27, 2017
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
Anup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Cancer Metastasis Reviews
|
December 31, 2013
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
Sarah Derks, Arjen H G Cleven, Veerle Melotte, et al.
Plos One
|
November 30, 2020
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
Anup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Cancer Chemotherapy and Pharmacology
|
January 23, 2014
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
Edward Sausville, Patricia Lorusso, Michael Carducci, et al.
Cancer
|
January 3, 2013
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials
Jung-min Lee, John L Hays, Anne M Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 16, 2014
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors
Luis A Diaz, Christina M Coughlin, Susan C Weil, et al.
Investigational New Drugs
|
April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumors
James M Cleary, David A Reardon, Nilofer Azad, et al.
Page
of 5